{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:06:37Z","timestamp":1791547597702,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clon.2025.103873","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:15:34Z","timestamp":1747768534000},"page":"103873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Relationship Between Elective Neck Irradiation and Severe Lymphopenia in Patients Treated With Head and Neck Chemoradiotherapy"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1215-6793","authenticated-orcid":false,"given":"T.A.","family":"Mickel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.H.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2644-813X","authenticated-orcid":false,"given":"V.","family":"Avkshtol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.-L.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.S.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8371-4388","authenticated-orcid":false,"given":"B.D.","family":"Sumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10167","key":"10.1016\/j.clon.2025.103873_bib1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(18)31999-8","article-title":"Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomized, open-label, phase 3 study","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2025.103873_bib2","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck","volume":"375","author":"Ferris","year":"2016","journal-title":"NEJM"},{"issue":"4","key":"10.1016\/j.clon.2025.103873_bib3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1470-2045(20)30737-3","article-title":"Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial","volume":"22","author":"Lee","year":"2021","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.clon.2025.103873_bib4","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1470-2045(24)00100-1","article-title":"Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial","volume":"25","author":"Machiels","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2025.103873_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.radonc.2022.01.003","article-title":"The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: A systematic review and meta-analysis","volume":"168","author":"Dai","year":"2022","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2025.103873_bib6","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1038\/s41467-022-34676-w","article-title":"Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors","volume":"13","author":"Darragh","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.clon.2025.103873_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijrobp.2023.11.037","article-title":"The Role of Thoracic Vertebral Body Dosimetry in Minimizing Acute Hematologic Toxicities of Patients With Non-Small Cell Lung Cancer Receiving Lung Radiation Therapy and Immunotherapy","volume":"119","author":"Ma","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.clon.2025.103873_bib8","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1016\/j.clon.2023.04.003","article-title":"Prediction of Radiation-induced Lymphopenia following Exposure of the Thoracic Region and Associated Risk of Infections and Mortality","volume":"35","author":"Terrones-Campos","year":"2023","journal-title":"Clin Oncol (R Coll Radiol"},{"issue":"1","key":"10.1016\/j.clon.2025.103873_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2015.11.020","article-title":"Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation","volume":"118","author":"Sini","year":"2016","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.clon.2025.103873_bib10","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ijrobp.2020.09.063","article-title":"Prospective Phase 2 Study of Radiation Therapy Dose and Volume De-escalation for Elective Neck Treatment of Oropharyngeal and Laryngeal Cancer","volume":"109","author":"Sher","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"10.1016\/j.clon.2025.103873_bib11","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1158\/1078-0432.CCR-23-0334","article-title":"Efficacy and Quality-of-Life Following Involved Nodal Radiotherapy for Head and Neck Squamous Cell Carcinoma: The INRT-AIR Phase II Clinical Trial","volume":"29","author":"Sher","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.clon.2025.103873_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.canrad.2022.08.008","article-title":"Effect of lymphoid volume irradiation on radiation-induced lymphopenia in head and neck cancer","volume":"27","author":"C\u00e9saire","year":"2023","journal-title":"Cancer Radiother"},{"issue":"10","key":"10.1016\/j.clon.2025.103873_bib13","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jtho.2020.06.008","article-title":"Radiotherapy-Related Lymphopenia Affects Overall Survival in Patients With Lung Cancer","volume":"15","author":"Abravan","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.clon.2025.103873_bib14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ijrobp.2022.12.030","article-title":"Proton and carbon ion radiation therapy decreased severe lymphopenia by reducing thoracic vertebra and aortic doses in non-small cell lung cancer versus intensity modulated radiation therapy","volume":"116","author":"Li","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2025.103873_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/neuonc\/noaa182","article-title":"Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons","volume":"23","author":"Mohan","year":"2021","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.clon.2025.103873_bib16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2020.12.019","article-title":"Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy","volume":"156","author":"Kim","year":"2021","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.clon.2025.103873_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/JHC.S282062","article-title":"Radiation-associated lymphopenia and outcomes of patients with unresectable hepatocellular carcinoma treated with radiotherapy","volume":"3","author":"De","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"10.1016\/j.clon.2025.103873_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.adro.2018.09.004","article-title":"A comparison of grade 4 lymphopenia with proton versus photon radiation therapy for esophageal cancer","volume":"4","author":"Routman","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.clon.2025.103873_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2022.10.019","article-title":"Lymphocyte sparing normal tissue effects in the clinc(lymphoTEC): a systemic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy","volume":"177","author":"Venkatesulu","year":"2022","journal-title":"Radiother Oncol"},{"issue":"24","key":"10.1016\/j.clon.2025.103873_bib20","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.3390\/cancers13246193","article-title":"Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617","volume":"13","author":"Jin","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clon.2025.103873_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1066255","article-title":"Higher Radiation Dose on Immune Cells is Associated with Radiation-Induced Lymphopenia and Worse Prognosis in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma","volume":"14","author":"Qiu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.clon.2025.103873_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.radonc.2021.10.015","article-title":"Pelvic bone marrow sparing radiotherapy for cervical cancer: A systemic review and meta-analysis","volume":"165","author":"Zhou","year":"2021","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.clon.2025.103873_bib23","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.adro.2018.08.014","article-title":"Field Size Effects on the Risk and Severity of Treatment-Induced Lymphopenia in Patients Undergoing Radiation Therapy for Solid Tumors","volume":"3","author":"Ellsworth","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.clon.2025.103873_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A Systematic Review of the Influence of Radiation-Induced Lymphopenia on Survival Outcomes in Solid Tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.clon.2025.103873_bib25","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ijrobp.2021.07.1695","article-title":"The Influence of Severe Radiation-Induced Lymphopenia on Overall Survival in Solid Tumors: A Systematic Review and Meta-Analysis","volume":"111","author":"Damen","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clon.2025.103873_bib26","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","article-title":"Lymphopenia Association with Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes","volume":"89","author":"Tang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2025.103873_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.radonc.2019.03.008","article-title":"Post-Treatment Lymphocytopenia, Integral Body Dose and Overall Survival in Lung Cancer Patients Treated with Radical Radiotherapy","volume":"135","author":"Joseph","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2025.103873_bib28","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3389\/fonc.2019.01488","article-title":"Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy","volume":"9","author":"Zhao","year":"2019","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.clon.2025.103873_bib29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s13277-015-3888-y","article-title":"Radiation-Related Lymphopenia as a New Prognostic Factor in Limited-Stage Small Cell Lung Cancer","volume":"37","author":"Cho","year":"2016","journal-title":"Tumour Biol"},{"issue":"Suppl 1","key":"10.1016\/j.clon.2025.103873_bib30","first-page":"E1061","article-title":"Minimum Absolute Lymphocyte Count During Radiotherapy as a New Prognostic Factor for Nasopharyngeal Cancer","volume":"38","author":"Cho","year":"2016","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.clon.2025.103873_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4143\/crt.2016.595","article-title":"The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients","volume":"50","author":"Liu","year":"2018","journal-title":"Cancer Res Treat"},{"issue":"10212","key":"10.1016\/j.clon.2025.103873_bib32","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655525001281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655525001281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:44:57Z","timestamp":1752626697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655525001281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":32,"alternative-id":["S0936655525001281"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2025.103873","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship Between Elective Neck Irradiation and Severe Lymphopenia in Patients Treated With Head and Neck Chemoradiotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2025.103873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103873"}}